Karen Bedard and Karl-Heinz Krause
Karen Bedard and Karl-Heinz Krause
Karen Bedard and Karl-Heinz Krause
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
282 KAREN BEDARD AND KARL-HEINZ KRAUSE<br />
423)]. Note that mitochondrial ROS might also contribute<br />
to COX-2 expression (974).<br />
2. ROS <strong>and</strong> NOX in kidney pathophysiology<br />
In general, enhanced generation of ROS by NOX<br />
enzymes is thought to participate in nephrotoxic pathways.<br />
A) DIABETIC NEPHROPATHY. A role for NOX-derived ROS<br />
in diabetic nephropathy is now widely accepted (343, 515,<br />
539, 779). There are also first indications that (nonspecific)<br />
NADPH oxidase inhibitors may prevent renal damage<br />
in diabetic animals (37). However, there is still a<br />
debate regarding the NOX isoforms involved in mediating<br />
ROS-dependent tissue damage in diabetic nephropathy.<br />
Upregulation of NOX2 or subunits thereof have been<br />
reported in several studies (37, 264, 310, 779), <strong>and</strong> antisense<br />
RNA against p47 phox prevents high glucose-induced<br />
ROS generation in mesengial cells (393). Increased expression<br />
of NOX4 mRNA <strong>and</strong> protein in diabetic nephropathy<br />
has also been reported (250, 310), <strong>and</strong> treatment of<br />
diabetic animals with NOX4 antisense RNA decreases<br />
kidney pathology (310). It is tempting to speculate that<br />
NOX2 <strong>and</strong> NOX4 act synergistically in generating ROSdependent<br />
damage in diabetic nephropathy, but more<br />
studies will be necessary to clarify this point.<br />
3. High salt <strong>and</strong> hypertension<br />
High-salt diet induces p47 phox <strong>and</strong> NOX2 mRNA expression<br />
in the renal cortex (276, 464), <strong>and</strong> increased<br />
expression of p47 phox <strong>and</strong> NOX2 mRNA <strong>and</strong> protein was<br />
found in the kidney of spontaneously hypertensive rats<br />
(11, 132, 984). A moderately decreased blood pressure in<br />
NOX2-deficient animals has also been reported (935), but<br />
it is not clear whether vascular NOX2 or renal NOX2 is<br />
most relevant for this decrease in blood pressure.<br />
4. Others<br />
Chronic renal failure is associated with elevated<br />
NOX2 protein expression (911), <strong>and</strong> there is also evidence<br />
that ROS generation is involved in the pathogenesis of<br />
acute renal failure (651). Aminoglycosides are thought to<br />
induce nephrotoxicity at least in part through ROS. They<br />
have been suggested to stimulate mitochondrial ROS generation<br />
in the renal cortex (928), although more recent<br />
results suggest that a NOX enzyme participates in aminoglycoside-dependent<br />
mesangial cell contraction <strong>and</strong><br />
proliferation (583).<br />
H. Lung <strong>and</strong> Airways<br />
Total lung or airway mRNA contains solid amounts of<br />
NOX2 (143, 454) <strong>and</strong> DUOX1 (299) as well as low amounts<br />
of NOX4 (143). The bulk of the NOX2 is likely due to<br />
Physiol Rev VOL 87 JANUARY 2007 www.prv.org<br />
alveolar macrophages, typical phagocytes which are crucial<br />
for host defense, but which also participate in a<br />
variety of inflammatory lung diseases. The low-level expression<br />
of NOX4 <strong>and</strong> the lack of detection of other NOX<br />
enzymes, however, does not exclude an important role of<br />
these isoforms in a particular pulmonary cell type.<br />
1. Airway epithelium<br />
Airway epithelia are able to generate ROS (139, 271).<br />
NOX isoforms expressed in airway epithelia are DUOX1<br />
(299, 352, 513, 794), DUOX2 (271, 352, 794), <strong>and</strong> possibly<br />
NOX2 (513). Duox1 expression is increased by treatment<br />
with Th2 cytokines IL-4 <strong>and</strong> IL-13, whereas Duox2 expression<br />
is induced after treatment with the Th1 cytokine<br />
IFN-� (352). Proposed functions for NOX enzymes in<br />
airway epithelia include host defense (299), acid production<br />
(794), response to mechanical stress (139), regulation<br />
of gene expression (513, 684), activation of TNF-�-converting<br />
enzyme leading to mucin expression (808), <strong>and</strong><br />
induction of cell death (986).<br />
2. Alveolar cells<br />
Type II pneumocytes release ROS (459, 706). This<br />
ROS generation has been attributed in part to mitochondria<br />
(459, 706), <strong>and</strong> at least in part to an NADPH oxidaselike<br />
enzyme (706, 905). However, so far no NOX isoforms<br />
have been reported. Proposed functions of ROS generation<br />
in alveolar type II cells include host defense (905),<br />
induction of IL-8 expression (200), <strong>and</strong> oxidative protein<br />
inactivation (930).<br />
3. Lung vasculature <strong>and</strong> pulmonary hypertension<br />
NADPH oxidase-dependent ROS generation has been<br />
described in pulmonary endothelial cells (263, 609, 685)<br />
<strong>and</strong> smooth muscle cells (104). It has been suggested that<br />
NOX4 is the predominant NOX isoform in pulmonary<br />
smooth muscle (383). Proposed function of NOX-derived<br />
ROS include NF�B activation (104), MAP kinase activation<br />
(685), <strong>and</strong> cell proliferation (104, 609). It appears that<br />
in the pulmonary vasculature, NOX enzymes play a particularly<br />
important role in the response to changes in the<br />
oxygen concentration. Paradoxically, an increase in ROS<br />
generation is observed in response to both hyperoxia<br />
(154) <strong>and</strong> hypoxia (263, 581, 943, 944). Hypoxia-induced<br />
NOX activation is thought to lead to ROS-dependent vasoconstriction.<br />
Such a model would suggest that NOX<br />
activation plays an important role in pulmonary hypertension<br />
(432). Indeed, there are many experimental data that<br />
hint towards such a role of NOX, including an NADPH<br />
oxidase activation in response to stimuli thought to be<br />
involved in the development of pulmonary hypertension<br />
(218, 326, 587), an enhancement of pulmonary vasoconstriction<br />
through exogenously added superoxide (549),<br />
Downloaded from<br />
physrev.physiology.org on February 2, 2010